Proton-pump inhibitors in peptic ulcer disease

The Lancet

Volumn 372, Issue 9645, 2008, Pages 1198-1200

  Chan, Francis KL ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR;

ARTICLE; BLEEDING; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ECONOMIC ASPECT; ENDOSCOPIC THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMODYNAMICS; HEMOSTASIS; HOSPITAL ADMISSION; HUMAN; MORBIDITY; MORTALITY; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PERFORATION; PRIORITY JOURNAL; PROPHYLAXIS; TREATMENT OUTCOME;

EID: 53049092928     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61497-X     Document Type: Note

References (16)

1. Lau J.Y., Sung J.J., Lee K.K., et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 343 (2000) 310-316
2. Lau J.Y., Leung W.K., Wu J.C., et al. Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med 356 (2007) 1631-1640
3. Dorward S., Sreedharan A., Leontiadis G.I., Howden C.W., Moayyedi P., and Forman D. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev 4 (2006) CD005415.
4. Tsoi K.K.F., Lau J., and Sung J. Cost-effectiveness analysis of high-dose omeprazole infusion before endoscopy for patients with upper-GI bleeding. Gastrointest Endosc 67 (2008) 1056-1063
5. Al-Sabah S., Barkun A.N., Herba K., et al. Cost-effectiveness of proton pump inhibition before endoscopy in upper gastrointestinal bleeding. Clin Gastroenterol Hepatol 6 (2008) 418-425
6. Leontiadis G.I., Sharma V.K., and Howden C.W. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev 1 (2006) CD002094.
7. Leontiadis G.I., Sreedharan A., Dorward S., et al. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol Assess 11 (2007) 1-164
8. Barkun A., Bardou M., and Marshall J.K. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 139 (2003) 843-857
9. Chan FK, Abraham NS, Scheiman JM, Laine L. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-Inflammatory Drugs and Anti-Platelet Agents. Am J Gastroenterol (in press).
10. Rostom A., Dubé C., Wells G., et al. Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev 4 (2002) CD002296.
11. Rostom A., Muir K., Dubé C., et al. Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review. Clin Gastroenterol Hepatol 5 (2007) 818-828
12. Chan F.K., Hung L.C., Suen B.Y., et al. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 347 (2002) 2104-2110
13. Chan F.K., Hung L.C., Suen B.Y., et al. Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial. Gastroenterology 127 (2004) 1038-1043
14. Chan F.K., Wong V.W., Suen B.Y., et al. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial. Lancet 369 (2007) 1621-1626
15. Brown T.J., Hooper L., Elliott R.A., et al. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling. Health Technol Assess 10 (2006) iii-iv xi-xiii, 1-183.
16. Elliott R.A., Hooper L., Payne K., Brown T.J., Roberts C., and Symmons D. Preventing non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: are older strategies more cost-effective in the general population?. Rheumatology 45 (2006) 606-613